CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024

Industry: Pharmaceutical Preparations
SEC CIK: 0001042074

SEC filings (opens in a new tab)

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding CymaBay Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of CBAY: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Of which not filed for Q1 2023	Q1 2023	Change
Holders	118	1	140	+23
Shares	65.3M	131.0K	88.8M	+23.7M (+36.4%)
Value	$404.2M	$821.6K	$774.9M	+$371.5M (+92.1%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CBAY in Q1 2023
Institution	Shares	Value	% of portfolio
Bain Capital Life Sciences Investors, LLC	2,500,000	$21.8M	2.72%
Cormorant Asset Management, LP	1,271,429	$11.1M	0.73%
Voloridge Investment Management, LLC	643,812	$5.61M	0.03%
Jennison Associates LLC	623,663	$5.44M	0.00%
Healthcare of Ontario Pension Plan Trust Fund	386,600	$3.37M	0.02%
Woodline Partners LP	285,717	$2.49M	0.04%
Swiss National Bank	182,700	$1.59M	0.00%
Artia Global Partners LP	169,277	$1.48M	0.59%
Wellington Management Group LLP	152,487	$1.33M	0.00%
Carlyle Group Inc.	131,036	$1.14M	0.03%
Verition Fund Management LLC	100,342	$875.0K	0.01%
Campbell & CO Investment Adviser LLC	79,479	$693.1K	0.13%
State of Wisconsin Investment Board	78,124	$681.2K	0.00%
Harvest Investment Services, LLC	76,956	$671.1K	0.52%
California State Teachers Retirement System	74,391	$648.7K	0.00%
UBS Asset Management Americas Inc	69,035	$602.0K	0.00%
Credit Suisse AG	65,746	$573.3K	0.00%
Trexquant Investment LP	63,886	$557.1K	0.02%
Raymond James Financial Services Advisors, Inc.	60,159	$524.6K	0.00%
Mackenzie Financial Corp	50,178	$437.6K	0.00%
Golden State Equity Partners	50,000	$436.0K	0.24%
Chartwell Investment Partners, LLC	46,655	$406.0K	0.02%
Connacht Asset Management LP	39,127	$341.2K	0.98%
Legal & General Group Plc	36,585	$319.0K	0.00%
Diametric Capital, LP	33,706	$293.9K	0.14%
Teacher Retirement System of Texas	26,086	$227.0K	0.00%
Arizona State Retirement System	24,536	$214.0K	0.00%
Point72 Asset Management, L.P.	20,597	$179.6K	0.00%
Point72 Middle East FZE	19,618	$171.1K	0.01%
Jefferies Financial Group Inc.	17,899	$156.1K	0.00%
Pictet Asset Management SA	15,707	$137.0K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	15,149	$132.1K	0.00%
Bank of Nova Scotia	13,554	$118.2K	0.00%
Profund Advisors LLC	13,203	$115.1K	0.01%
Prelude Capital Management, LLC	10,973	$95.7K	0.01%
CTC Capital Management, LLC	10,700	$93.3K	0.20%
Victory Capital Management Inc	10,077	$87.9K	0.00%
Great West Life Assurance Co	4,602	$40.0K	0.00%
US Bancorp	360	$3.14K	0.00%
TCI Wealth Advisors, Inc.	341	$2.97K	0.00%
Creative Planning	231	$2.02K	0.00%
Parallel Advisors, LLC	41	$358	0.00%

Sold out (19)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of CBAY in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Baker Bros. Advisors LP	2,170,464	$13.6M
Sio Capital Management, LLC	555,610	$3.48M
Walleye Capital LLC	488,894	$3.07M
EAM Global Investors LLC	311,808	$1.96M
DAFNA Capital Management LLC	171,059	$1.07M
CM Management, LLC	160,000	$1.00M
Schonfeld Strategic Advisors LLC	121,683	$763.0K
Ergoteles LLC	103,997	$652.1K
Conning Inc.	78,529	$492.4K
Fosun International Ltd	78,529	$492.4K
Cheyne Capital Management (UK) LLP	77,499	$485.9K
Jump Financial, LLC	70,801	$443.9K
Bank of Montreal	56,276	$354.0K
Rockefeller Capital Management L.P.	25,000	$156.0K
Walleye Trading LLC	24,412	$153.1K
Quantamental Technologies LLC	14,910	$93.5K
Ameriprise Financial Inc	11,561	$73.0K
Belvedere Trading LLC	4,695	$29.4K
Signaturefd, LLC	116	$727

Not filed for Q1 2023 yet (1)

Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CBAY in Q4 2022 that haven't filed for Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Abingworth LLP	131,036	$821.6K